Strategic Global Advisors’s PRA Health Sciences, Inc. PRAH Stock Holding History

Strategic Global Advisors’s Portfolio PRAH Stock Details PRAH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-5,986	Closed	-$550K	–	199
2018 Q4	$550K	Hold	5,986	–	–	0.2%	95
2018 Q3	$660K	Hold	5,986	–	–	0.2%	99
2018 Q2	$497K	Hold	5,986	–	–	0.13%	119
2018 Q1	$497K	Sell	5,986 -8,748	-59%	-$777K	0.17%	109
2017 Q4	$1.34M	Buy	14,734 +2,823	+24%	+$235K	0.44%	60
2017 Q3	$907K	Sell	11,911 -713	-6%	-$53.9K	0.35%	78
2017 Q2	$947K	Sell	12,624 -1,530	-11%	-$106K	0.35%	74
2017 Q1	$923K	Buy	14,154 +3,468	+32%	+$204K	0.33%	81
2016 Q4	$589K	Sell	10,686 -3,404	-24%	-$187K	0.22%	96
2016 Q3	$588K	Sell	14,090 -9	-0.1%	-$441	0.22%	95
2016 Q2	$589K	Hold	14,099	–	–	0.22%	94
2016 Q1	$603K	Buy	+14,099	New	+$596K	0.26%	88

Other funds holding PRAH

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Strategic Global Advisors's PRAH Position: Q1 2019 in Review

Strategic Global Advisors sold out of PRA Health Sciences, Inc. (PRAH) in Q1 2019, closing a stake of 5,986 shares — an estimated $550K sold.

Strategic Global Advisors first reported a position in PRAH in Q1 2016 and held it in 12 quarters. The position peaked at $1.34M in Q4 2017. 354 funds tracked by Wall St. Rank hold PRAH as of Q1 2019.

Strategic Global Advisors reported no remaining PRA Health Sciences, Inc. position as of Q1 2019 after selling out during the quarter.
Strategic Global Advisors sold 5,986 PRA Health Sciences, Inc. shares in Q1 2019, an estimated $550K.
Strategic Global Advisors first reported a position in PRA Health Sciences, Inc. in Q1 2016 and held it in 12 quarters.
Strategic Global Advisors's PRA Health Sciences, Inc. position peaked at $1.34M in Q4 2017.
354 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q1 2019.

Based on Strategic Global Advisors's 13F filing for Q1 2019, filed 13 May 2019.